Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticulate Drug-Delivery Systems: An Overview

Deepak Thassu, Y. Pathak, M. Deleers
Published 2007 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
nanoparticulate drug delivery system an overview nanoparticulate drug delivery system an overview nanoparticulate drug delivery system an overview nanoparticulate drug delivery system an overview pdf format nanotechnology for drug delivery: an overview nanoparticulate drug delivery novel approach for drug delivery download ebook nanoparticulate drug delivery system an design and evaluation ofnanoparticulatedrug herbal nanoparticles drug delivery system an overview 1 nanoparticulate drug-delivery systems: an overview lyotropic liquid crystal systems in drug delivery: a review a pharmacokinetic overview of nanotechnology-based drug nanoparticulate drug delivery system a solubility nanoparticulate drug delivery systems drugs and the prodrugbased nanoparticulate drug delivery strategies for 96 honda odyssey repair manual 42035 ebook | browserfame in situ gelling ophthalmic drug delivery system: an overview cancer nanotechnology: nanoparticulate drug delivery for extracellular stability of nanoparticulate drug carriers nanoparticle drug delivery market report nanoparticulate drug delivery systems drugs and the an outlook of divergent approaches for production of review on nasal drug delivery system with recent advancemnt review article nanoparticles – an overview nanoparticulate drug delivery novel approach for drug delivery asian journal of research in pharmaceutical sciences and targeted drug-delivery approaches by nanoparticulate casino dictionary gaming and business terms nanotherapeutics: drug delivery concepts in nanoscience 2006 chevy chevrolet hhr sales brochure ebook | ufcgymmatthews study guide for atas document about pimp your lesson prepare innovate motivate marketing research 9th edition wiley wired for war the robotics revolution and conflict in the
This paper references
10.1080/02652040400008457
Long-term shelf stability of amphiphilic β-cyclodextrin nanosphere suspensions monitored by dynamic light scattering and cryo-transmission electron microscopy
A. Géze (2004)
10.1023/A:1016121319668
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
B. Heurtault (2004)
10.1002/JPS.20366
Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-drying.
S. Yin (2005)
10.1016/J.JCONREL.2004.09.024
Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics.
F. Martin (2005)
10.1021/CR0300688
Self-assembled nanoreactors.
D. M. Vriezema (2005)
10.1023/B:PHAM.0000041463.56768.ec
Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo
C. Rudolph (2004)
10.1023/A:1025017502379
Novel Polyester-Polysaccharide Nanoparticles
C. Lemarchand (2004)
10.1016/S0168-3659(02)00009-3
Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery.
A. Kabanov (2002)
10.1016/J.JCONREL.2004.04.024
Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
K. Kogure (2004)
10.1016/J.JCONREL.2004.09.021
Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound.
Z. Gao (2005)
10.1023/A:1020404615898
Uptake of FITC-Chitosan Nanoparticles by A549 Cells
M. Huang (2004)
10.1016/S0142-9612(03)00021-8
Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles.
Y. Hu (2003)
10.1002/JPS.20227
Measurement of process-dependent material properties of pharmaceutical solids by nanoindentation.
Xiangmin Liao (2005)
10.1016/S0927-7765(03)00096-1
Interfacial stability of lipid nanocapsules
B. Heurtault (2003)
10.1080/0265204031000093032
Microencapsulation of lipid nanoparticles containing lipophilic drug
K. E. Lee (2003)
10.1016/0168-3659(94)90118-X
Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates
G. Kwon (1994)
10.1186/1479-0556-1-3
Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma
M. Kumar (2003)
10.1016/J.JCONREL.2004.07.035
Intercalation, delivery, and expression of the gene encoding green fluorescence protein utilizing nanobiohybrids.
Katherine M Tyner (2004)
10.1023/B:PHAM.0000016249.52831.a5
Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation
M. Huang (2004)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1016/S0378-5173(02)00268-5
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).
E. Ugazio (2002)
10.1080/02652040010018056
Production of solid lipid nanoparticles (SLN): scaling up feasibilities
A. Dingler (2002)
10.1023/B:PHAM.0000036917.75634.be
Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-Out, Emulsification-Diffusion, and Nanoprecipitation Methods
S. Galindo-Rodriguez (2004)
10.1021/JA0366235
Raman dye-labeled nanoparticle probes for proteins.
Y. Cao (2003)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I45.10
Major determinants in hepatic disposition of polystyrene nanospheres: implication for rational design of particulate drug carriers.
K. Ogawara (2002)
10.1016/J.JCONREL.2004.10.014
Cell targeting by a generic receptor-targeted polymer nanocontainer platform.
P. Brož (2005)
10.1016/S0168-3659(01)00397-2
Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
C. Pérez (2001)
10.1016/J.JCONREL.2004.01.029
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.
Heidrun Wartlick (2004)
10.1016/J.JCONREL.2004.11.036
Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery.
Y. Yamaguchi (2005)
10.1016/S0168-3659(02)00320-6
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
L. Mu (2003)
10.1016/S0168-3659(01)00299-1
Structure and design of polymeric surfactant-based drug delivery systems.
V. Torchilin (2001)
10.1007/s11095-004-1872-0
A Novel, Lipid-Free Nanodispersion Formulation of Propofol and Its Characterization
Hongming Chen (2004)
10.1016/S0168-3659(03)00342-0
Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer.
G. Verreck (2003)
10.1002/ANIE.200390204
Vesicles and polymerized vesicles from thiophene-containing rod-coil block copolymers.
D. M. Vriezema (2003)
10.1016/S0927-7765(99)00067-3
Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel
H. Burt (1999)
10.1517/17425247.1.1.87
Thiomers for oral delivery of hydrophilic macromolecular drugs
A. Bernkop-Schnürch (2004)
10.1007/s11095-004-9005-3
Polymeric Micelles Based on Amphiphilic Scorpion-like Macromolecules: Novel Carriers for Water-Insoluble Drugs
J. Djordjevic (2004)
10.1023/A:1023803706746
Development and in Vivo Evaluation of an Oral Delivery System for Low Molecular Weight Heparin Based on Thiolated Polycarbophil
C. Kast (2004)
10.1016/S0169-409X(00)00118-6
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
10.1016/S0169-409X(01)00171-5
Chitosan as a novel nasal delivery system for vaccines.
L. Illum (2001)
10.1016/J.JCONREL.2004.11.015
Drug-incorporating calcium carbonate nanoparticles for a new delivery system.
Yukio Ueno (2005)
10.1023/B:PHAM.0000026432.75781.cb
Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity
A. M. de Campos (2004)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1023/B:PHAM.0000003376.57954.2a
Novel Polysaccharide-Decorated Poly(Isobutyl Cyanoacrylate) Nanoparticles
C. Chauvierre (2004)
10.1016/S0168-3659(03)00014-2
Nanotechnological approaches for the delivery of macromolecules.
D. J. Crommelin (2003)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1007/978-0-387-85600-1_20
APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE
C. Bárcena (2003)
10.1016/J.JCONREL.2004.01.010
Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice.
Leyang Zhang (2004)
10.1016/S0169-409X(02)00015-7
Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery.
A. Lavasanifar (2002)
10.1016/0014-2964(80)90049-3
Intracellular penetration of liposomes containing a water insoluble antimitotic drug in L1210 cells.
J. Frühling (1980)
10.1016/J.IJPHARM.2005.05.014
Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
J. Hecq (2005)
10.1016/J.JCONREL.2004.07.028
Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles.
K. Ogawara (2004)
10.1023/B:PHAM.0000019302.26097.cc
3H Dendrimer Nanoparticle Organ/Tumor Distribution
Shraddha S. Nigavekar (2004)
10.1016/J.JCONREL.2003.08.005
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.
C. Vauthier (2003)
10.1016/J.JCONREL.2004.02.003
Folate receptor targeted biodegradable polymeric doxorubicin micelles.
H. Yoo (2004)
10.1002/JPS.10368
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.
R. Cavalli (2003)
10.1021/BC010102U
Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization.
H. Ihre (2002)
10.1021/JA00140A040
Protein-Sized Quantum Dot Luminescence Can Distinguish between "Straight", "Bent", and "Kinked" Oligonucleotides
R. Mahtab (1995)
10.1016/S0168-3659(03)00231-1
Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect.
Yoen Ju Son (2003)
10.1016/S0169-409X(01)00222-8
Advanced drug delivery devices via self-assembly of amphiphilic block copolymers.
A. Rösler (2001)
10.1016/J.JCONREL.2004.11.018
Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles.
X. Xiong (2005)
10.1007/s11095-004-1188-0
Engineering Polysaccharide-Based Polymeric Micelles to Enhance Permeability of Cyclosporin A Across Caco-2 Cells
M. Francis (2004)
10.1016/J.BIOMATERIALS.2004.07.047
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
S. Balthasar (2005)
10.1016/J.EJPB.2006.05.008
Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
J. Hecq (2006)
10.1021/BC010103M
Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation.
O. L. Padilla De Jesús (2002)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1021/MA035789N
Electroformed giant vesicles from thiophene-containing rod-coil diblock copolymers
D. M. Vriezema (2004)
10.1016/J.EJPB.2003.10.015
Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer.
K. Tabatt (2004)
10.1126/SCIENCE.1088755
Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins
J. Nam (2003)
10.1002/9780470152928.CH1
Biological Applications of Multifunctional Magnetic Nanowires
D. H. Reich (2003)
10.1023/A:1023450006281
Preparation and Characterization of Nanofibers Containing Amorphous Drug Dispersions Generated by Electrostatic Spinning
G. Verreck (2004)
10.1016/S0939-6411(00)00143-0
Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
R. Gref (2001)
10.1016/J.JCONREL.2004.07.003
Hydrotropic polymer micelle system for delivery of paclitaxel.
K. Huh (2005)
10.1016/J.JCONREL.2003.05.002
Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer.
Guo-Dong Zhang (2003)
10.1016/S0168-3659(03)00066-X
Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties.
P. Arbós (2003)
10.1016/S0168-3659(03)00098-1
Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres.
S. De (2003)
10.1016/J.ADDR.2003.09.001
Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery.
B. Ziaie (2004)
10.1021/BC970045Y
Capture of HIV-1 gp120 and Virions by Lectin-Immobilized Polystyrene Nanospheres†
M. Akashi (1998)
10.1016/S0142-9612(00)00122-8
A biodegradable polymer scaffold for delivery of osteotropic factors.
K. Whang (2000)
10.1016/J.JCONREL.2003.05.001
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.
A. Bernkop-Schnürch (2003)
10.1016/J.JCONREL.2003.12.027
Nanobiohybrids as delivery vehicles for camptothecin.
Katherine M. Tyner (2004)
10.1016/S0168-3659(03)00097-X
Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers.
Y. K. Luu (2003)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
10.1111/j.2042-7158.1996.tb03911.x
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
P. Calvo (1996)
10.1016/J.JCONREL.2004.04.005
pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate.
Kun Na (2004)
10.1038/354056a0
Helical microtubules of graphitic carbon
S. Iijima (1991)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/J.JCONREL.2004.11.029
Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.
V. Vogel (2005)
10.1016/S0928-0987(00)00198-6
Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
M. C. Varela (2001)
10.1021/LA001226I
Physicochemical Evaluation of Nanoparticles Assembled from Poly(lactic acid)−Poly(ethylene glycol) (PLA−PEG) Block Copolymers as Drug Delivery Vehicles
T. Riley (2001)
10.1016/J.JCONREL.2004.09.008
In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide).
Miechel L T Zweers (2004)
10.1023/A:1012172722246
Stabilization of 10-Hydroxycamptothecin in Poly(lactide-co-glycolide) Microsphere Delivery Vehicles
A. Shenderova (2004)
10.7326/0003-4819-81-1-143_5
Protamines. Isolation, characterization, structure and function.
T. Ando (1973)
10.1080/02652040400000504
Physicochemical characterization of protamine-phosphorothioate nanoparticles
D. Lochmann (2004)
Inhibition of cationic liposomes of [3H]thymidine incorporation into DNA of L1210 cells.
G. Laurent (1981)
10.1023/B:PHAM.0000008054.80136.5a
Effects of High Hydrostatic Pressure on Several Sensitive Therapeutic Molecules and a Soft Nanodispersed Drug Delivery System
Y. Rigaldie (2004)
10.1016/S0168-3659(03)00241-4
Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors.
J. Williams (2003)
10.1016/S0168-3659(03)00211-6
An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.
A. Kabanov (2003)
10.1023/A:1025065418309
Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study
K. Jores (2004)
10.1517/14712598.2.6.633
Microfabrication technology for pancreatic cell encapsulation
T. Desai (2002)
10.1080/02652040400015411
Formulation and characterization of triclosan sub-micron emulsions and nanocapsules
F. Maestrelli (2004)
10.1016/S0376-7388(99)00062-9
Characterization of micromachined silicon membranes for immunoisolation and bioseparation applications
T. Desai (1999)
10.1109/JMEMS.2003.823215
A water-powered micro drug delivery system
Yu-Chuan Su (2004)
10.1016/S0169-409X(02)00017-0
Block copolymer micelles for delivery of gene and related compounds.
Y. Kakizawa (2002)
10.1016/J.JCONREL.2004.03.003
Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
Xue-qing Wang (2004)
10.1016/S0378-5173(98)00346-9
Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract.
S. Sakuma (1999)
10.1016/J.JCONREL.2004.04.019
Fabrication of porous hollow silica nanoparticles and their applications in drug release control.
Zhu-Zhu Li (2004)
10.1016/J.JCONREL.2003.12.020
Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery.
J. Park (2004)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I2.10
Nanocapsule technology: a review.
P. Couvreur (2002)
10.1023/A:1016064930502
Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique
B. Müller (2004)
10.1016/S0168-3659(03)00126-3
Chitosan-based gastrointestinal delivery systems.
Radi Hejazi (2003)
10.1063/1.1558672
Biological applications of multifunctional magnetic nanowires (invited)
D. H. Reich (2003)
10.1016/S0378-5173(02)00269-7
Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.
Soo-Jeong Lim (2002)
10.1016/S0168-3659(99)00223-0
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
V. Jenning (2000)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/S0378-5173(02)00180-1
Nanostructured lipid matrices for improved microencapsulation of drugs.
R. Mueller (2002)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1016/J.JCONREL.2004.02.024
Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption.
C. Olbrich (2004)
10.1186/1477-3155-2-3
Applications of nanoparticles in biology and medicine
OV Salata (2004)
10.1080/02652040410001729278
Nanoparticle-coated microparticles: preparation and characterization
R. Beck (2004)
10.1016/0192-0561(94)90036-1
Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules.
G. Barratt (1994)
10.1002/(SICI)1096-9071(199812)56:4<327::AID-JMV7>3.0.CO;2-A
Concanavalin A‐immobilized polystyrene nanospheres capture HIV‐1 virions and gp120: Potential approach towards prevention of viral transmission
T. Hayakawa (1998)
10.1016/S0378-5173(97)00076-8
Atovaquone and rifabutine-loaded nanocapsules: formulation studies
F. Dalençon (1997)
10.1016/J.JCONREL.2004.11.033
Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery.
H. Yoo (2005)
10.1146/ANNUREV.BIOENG.2.1.289
Microfabricated microneedles for gene and drug delivery.
D. Mcallister (2000)
10.1016/S0168-3659(03)00162-7
Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel
S. Lee (2003)
10.1023/A:1024470508758
Visualization of Insulin-Loaded Nanocapsules: In Vitro and in Vivo Studies After Oral Administration to Rats
H. Pinto-Alphandary (2004)
10.1016/J.JCONREL.2003.11.012
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
K. Jores (2004)
10.1007/s11095-004-1196-0
Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying
C. Dulieu (2004)
10.1016/S0008-6223(00)00250-5
Segmented and opened multi-walled carbon nanotubes
G. Maurin (2001)
10.1016/S0168-3659(99)00029-2
Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate).
J. E. Chung (1999)
10.1016/S0142-9612(00)00120-4
Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering.
W. Murphy (2000)
10.1186/1477-3155-2-12
Nanoparticles – known and unknown health risks
P. Hoet (2004)
10.1007/s11095-004-7667-5
A Folate Receptor–Targeted Lipid Nanoparticle Formulation for a Lipophilic Paclitaxel Prodrug
P. J. Stevens (2004)
10.1016/S0142-9612(02)00578-1
The production and characteristics of solid lipid nanoparticles (SLNs).
DongZhi Hou (2003)
10.1016/S0169-409X(02)00118-7
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
10.1111/j.1349-7006.2001.tb01114.x
Enhanced Vascular Permeability in Solid Tumor Involving Peroxynitrite and Matrix Metalloproteinases
J. Wu (2001)
10.1016/J.JCONREL.2004.02.029
Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes.
K. Tabatt (2004)
10.1002/JPS.10507
Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells.
Y. Mo (2004)
10.1016/J.JCONREL.2004.01.005
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
V. Venkateswarlu (2004)
10.1021/AR010162F
Materials science of carbon nanotubes: fabrication, integration, and properties of macroscopic structures of carbon nanotubes.
O. Zhou (2002)
10.1146/ANNUREV.BIOPHYS.29.1.27
Structure and function of lipid-DNA complexes for gene delivery.
S. Chesnoy (2000)
10.1023/A:1015897900363
The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker
B. Hubert (2004)
10.1088/0957-4484/7/3/009
Nanometre diameter fibres of polymer, produced by electrospinning
D. Reneker (1996)
10.1023/B:PHAM.0000029284.40637.69
A Novel One-Step Drug-Loading Procedure for Water-Soluble Amphiphilic Nanocarriers
E. Fournier (2004)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/J.JCONREL.2004.08.001
Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system.
V. Leitner (2004)
10.1002/JPS.10573
Biodegradable nanoparticles containing protein‐fatty acid complexes for oral delivery of salmon calcitonin
H. Yoo (2004)
10.1016/J.JCONREL.2004.07.032
Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders.
Soo-Jeong Lim (2004)
10.1016/J.JCONREL.2003.09.013
An overview of current delivery systems in cancer gene therapy.
Anas El-Aneed (2004)
10.1053/CLON.2000.9105
Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development.
K. Harrington (2000)
10.1126/SCIENCE.1078192
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
R. Savić (2003)
10.1016/S0169-409X(00)00124-1
Block copolymer micelles for drug delivery: design, characterization and biological significance.
K. Kataoka (2001)
10.1016/J.JCONREL.2004.02.020
Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
N. Dinauer (2004)
10.1016/S0168-3659(97)00040-0
Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers
S. Cammas (1997)
10.1073/pnas.0931428100
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
V. Torchilin (2003)
10.1109/84.749400
Silicon membrane nanofilters from sacrificial oxide removal
W. Chu (1999)
10.1038/nrd744
Building drug delivery into tissue engineering design
W. Saltzman (2002)
10.1002/(SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO;2-K
Dendrimers: From Design to Application-A Progress Report.
M. Fischer (1999)
10.1023/A:1016041326636
New Cationic Lipid Formulations for Gene Transfer
F. Liu (2004)
10.1038/nbt876
Small-scale systems for in vivo drug delivery
David A. LaVan (2003)
10.1002/ANGE.19250383903
Die neutralisierende Wirkung der aktivierten Bleicherden bei gesäuerten Schmierölen
O. Eckart (1925)
10.1016/S0168-3659(99)00245-X
Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents.
M. Liu (2000)



This paper is referenced by
10.3109/10837450.2012.705298
Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application
Genç Lütfi (2013)
10.1007/s00232-010-9271-4
Increased Cellular Uptake of Biocompatible Superparamagnetic Iron Oxide Nanoparticles into Malignant Cells by an External Magnetic Field
Sara Prijic (2010)
10.21516/2072-0076-2019-12-2-83-95
Клиническая интерпретация традиционных, незаслуженно забытых или недостаточно распространенных и перспективных способов доставки лекарственных средств в офтальмологии (часть 1)
А. В. Куроедов (2019)
10.5530/JYP.2017.9.68
Self-nanoemulsifying Drug Delivery System (Snedds) for Topical Delivery of Mangosteen Peels (Garcinia Mangostana L.,): Formulation Design and In vitro Studies
Liza Pratiwi (2017)
Synthesis and Characterization of Chitosan Nanoparticles from theshells of crabs(Portunus pelagicus) and Application as Antimicrobial Fatahu
Fatahu (2016)
10.3109/15376516.2015.1070229
Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress
H. R. Sadeghnia (2015)
10.1007/978-94-007-6010-3_10
In Silico Research in Drug Delivery Systems
A. F. Ferreira (2013)
10.37285/ijpsn.2014.7.1.10
Formulation and Evaluation of Mefloquine Hydrochloride Nanoparticles
D. Gupta (2014)
INTERACTIONS OF THE MESOPOROUS SILICA-CAPTOPRIL NANOCOMPOSITES WITH SOME METABOLIC PROCESSES IN MONKEY KIDNEY VERO CELLS
R. F. POPOVICIa (2011)
Aplicada ao Tratamento do Glaucoma
Mariana Reis Santos (2014)
10.1016/J.MCNA.2007.05.007
The ethical dimensions of nanomedicine.
R. Bawa (2007)
10.1007/s13233-012-0134-y
Nanotechnology and carbon nanotubes; A review of potential in drug delivery
Edwin Kamalha (2012)
10.1201/B17191-2
Introduction—Biointeractions of Nanomaterials: Challenges and Solutions
V. Sutariya (2014)
10.1007/s10439-015-1331-6
Effect of Varying Magnetic Fields on Targeted Gene Delivery of Nucleic Acid-Based Molecules
O. Oral (2015)
Regulating nanoparticles : a complex balancing act
Sylvia Isabelle Sarah Dean (2016)
10.1007/s12272-011-1012-4
Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment
P. Iangcharoen (2011)
Nanomedicine: general aspects of a promissory future
Duani Blanco Bea (2011)
10.1080/10643389.2012.671750
Nanopesticides: State of Knowledge, Environmental Fate, and Exposure Modeling
M. Kah (2013)
10.1016/j.jcis.2010.09.076
Preparation of magnetic polymer particles with nanoparticles of Fe(0).
S. Buendía (2011)
10.1081/e-ebpp-120049898
Supramolecular Polymeric Nanoparticles
Salman Hassanzadeh (2016)
Preparation and evaluation of solid supersaturable self- nanoemulsifying drug delivery system of candesartan cilexetil
Safa F. Albaidhani (2019)
Nanosizing of drugs: Effect on dissolution rate
S. M. Dizaj (2015)
10.2174/1872210513666190104122032
Role of Nanotechnology in Diabetic Management.
Reena Siwach (2019)
10.5772/2354
Trends in Vital Food and Control Engineering
A. Eissa (2012)
10.1007/978-3-642-31107-9_27
Lipids as Biological Materials for Nanoparticulate Delivery
I. P. Kaur (2014)
10.22270/JDDT.V0I0.883
NANOPARTICULATE DRUG DELIVERY SYSTEMS: PROMISING APPROACHES FOR DRUG DELIVERY
Srinivas Lankalapalli (2014)
10.5772/38888
Continuous Membrane Bioreactor (CMBR) to Produce Nanoparticles from Milk Components
Vanessa Nieto-Nieto (2012)
10.1016/j.biopha.2018.12.133
Applications of nanotechnology in drug delivery to the central nervous system.
M. Saeedi (2019)
REVIEW ARTICLE: CARBON DOTS: A NOBEL NANO CARRIER
Saurabh Pandey (2013)
10.1088/1361-6439/AAE5AE
Single-cell electroporation: current trends, applications and future prospects
Srabani Kar (2018)
10.1039/C7RA02437A
Functional responsive superparamagnetic core/shell nanoparticles and their drug release properties
Zied Ferjaoui (2017)
INTERACTIONS OF THE MESOPOROUS SILICA-CAPTOPRIL NANOCOMPOSITES WITH SOME METABOLIC PROCESSES IN MONKEY KIDNEY VERO CELLS
Roxana Popovici (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar